22nd Century Group, Inc. (XXII) Stock Analysis & Investment Frameworks
22nd Century Group, Inc. (XXII) stock analysis on Invetso. Review 22nd Century Group, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
22nd Century Group, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Consumer Defensive
- Industry: Tobacco
- Country: US
22nd Century Group, Inc. Key Financial Metrics
- Market Cap: $686797.00
- Revenue: $7.05M
- ROE: -20.47%
- ROIC: -59.48%
- Dividend Yield: N/A
About 22nd Century Group, Inc.
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
22nd Century Group, Inc. Investment Frameworks
Invetso analyzes 22nd Century Group, Inc. (XXII) across the following frameworks:
- 22nd Century Group, Inc. 10Y Growth Potential
- 22nd Century Group, Inc. Scenario Analysis
- 22nd Century Group, Inc. Risks & Opportunities
- 22nd Century Group, Inc. Economic Moat
- 22nd Century Group, Inc. Business Model
- 22nd Century Group, Inc. Management
- 22nd Century Group, Inc. SWOT Analysis
- 22nd Century Group, Inc. Porter's 5 Forces
- 22nd Century Group, Inc. PESTLE Analysis
- 22nd Century Group, Inc. ESG Analysis